89 related articles for article (PubMed ID: 14517889)
41. Retraction: Bruder, L. et al. Transcatheter Decellularized Tissue-Engineered Heart Valve (dTEHV) Grown on Polyglycolic Acid (PGA) Scaffold Coated with P4HB Shows Improved Functionality over 52 Weeks due to Polyether-Ether-Ketone (PEEK) Insert.
Bruder L; Brakmann K; Stegner V; Sigler M; Berger F; Schmitt B
J Funct Biomater; 2019 Jan; 10(1):. PubMed ID: 30669502
[TBL] [Abstract][Full Text] [Related]
42. Small-diameter vascular tissue engineering.
Seifu DG; Purnama A; Mequanint K; Mantovani D
Nat Rev Cardiol; 2013 Jul; 10(7):410-21. PubMed ID: 23689702
[TBL] [Abstract][Full Text] [Related]
43. Modulation of Smooth Muscle Cell Phenotype for Translation of Tissue-Engineered Vascular Grafts.
Pineda-Castillo SA; Acar H; Detamore MS; Holzapfel GA; Lee CH
Tissue Eng Part B Rev; 2023 Oct; 29(5):574-588. PubMed ID: 37166394
[TBL] [Abstract][Full Text] [Related]
44. Vascularized Tissue Organoids.
Strobel HA; Moss SM; Hoying JB
Bioengineering (Basel); 2023 Jan; 10(2):. PubMed ID: 36829618
[TBL] [Abstract][Full Text] [Related]
45. 3D bioprinting of an implantable xeno-free vascularized human skin graft.
Baltazar T; Jiang B; Moncayo A; Merola J; Albanna MZ; Saltzman WM; Pober JS
Bioeng Transl Med; 2023 Jan; 8(1):e10324. PubMed ID: 36684084
[TBL] [Abstract][Full Text] [Related]
46. Challenges and Possibilities of Cell-Based Tissue-Engineered Vascular Grafts.
Saito J; Kaneko M; Ishikawa Y; Yokoyama U
Cyborg Bionic Syst; 2021; 2021():1532103. PubMed ID: 36285145
[TBL] [Abstract][Full Text] [Related]
47. Tissue engineering of the gastrointestinal tract: the historic path to translation.
Collier CA; Mendiondo C; Raghavan S
J Biol Eng; 2022 Apr; 16(1):9. PubMed ID: 35379299
[TBL] [Abstract][Full Text] [Related]
48. Monitoring the Remodeling of Biohybrid Tissue-Engineered Vascular Grafts by Multimodal Molecular Imaging.
Rama E; Mohapatra SR; Melcher C; Nolte T; Dadfar SM; Brueck R; Pathak V; Rix A; Gries T; Schulz V; Lammers T; Apel C; Jockenhoevel S; Kiessling F
Adv Sci (Weinh); 2022 Apr; 9(10):e2105783. PubMed ID: 35119216
[TBL] [Abstract][Full Text] [Related]
49. Polymer-free corticosteroid dimer implants for controlled and sustained drug delivery.
Battiston K; Parrag I; Statham M; Louka D; Fischer H; Mackey G; Daley A; Gu F; Baldwin E; Yang B; Muirhead B; Hicks EA; Sheardown H; Kalachev L; Crean C; Edelman J; Santerre JP; Naimark W
Nat Commun; 2021 May; 12(1):2875. PubMed ID: 34001908
[TBL] [Abstract][Full Text] [Related]
50. Biofabrication of tissue engineering vascular systems.
Zhang Q; Bosch-Rué È; Pérez RA; Truskey GA
APL Bioeng; 2021 Jun; 5(2):021507. PubMed ID: 33981941
[TBL] [Abstract][Full Text] [Related]
51. Citrate Crosslinked Poly(Glycerol Sebacate) with Tunable Elastomeric Properties.
Risley BB; Ding X; Chen Y; Miller PG; Wang Y
Macromol Biosci; 2021 Feb; 21(2):e2000301. PubMed ID: 33205616
[TBL] [Abstract][Full Text] [Related]
52. Fas ligand and nitric oxide combination to control smooth muscle growth while sparing endothelium.
Kural MH; Wang J; Gui L; Yuan Y; Li G; Leiby KL; Quijano E; Tellides G; Saltzman WM; Niklason LE
Biomaterials; 2019 Aug; 212():28-38. PubMed ID: 31102854
[TBL] [Abstract][Full Text] [Related]
53. Targeted Delivery of Bioactive Molecules for Vascular Intervention and Tissue Engineering.
Strobel HA; Qendro EI; Alsberg E; Rolle MW
Front Pharmacol; 2018; 9():1329. PubMed ID: 30519186
[TBL] [Abstract][Full Text] [Related]
54. Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery.
Iop L; Palmosi T; Dal Sasso E; Gerosa G
J Thorac Dis; 2018 Jul; 10(Suppl 20):S2390-S2411. PubMed ID: 30123578
[TBL] [Abstract][Full Text] [Related]
55. Rapid Endothelialization of Off-the-Shelf Small Diameter Silk Vascular Grafts.
Filipe EC; Santos M; Hung J; Lee BSL; Yang N; Chan AHP; Ng MKC; Rnjak-Kovacina J; Wise SG
JACC Basic Transl Sci; 2018 Feb; 3(1):38-53. PubMed ID: 30062193
[TBL] [Abstract][Full Text] [Related]
56. Delivery of Antioxidant and Anti-inflammatory Agents for Tissue Engineered Vascular Grafts.
Washington KS; Bashur CA
Front Pharmacol; 2017; 8():659. PubMed ID: 29033836
[TBL] [Abstract][Full Text] [Related]
57. Vascular smooth muscle cells derived from inbred swine induced pluripotent stem cells for vascular tissue engineering.
Luo J; Qin L; Kural MH; Schwan J; Li X; Bartulos O; Cong XQ; Ren Y; Gui L; Li G; Ellis MW; Li P; Kotton DN; Dardik A; Pober JS; Tellides G; Rolle M; Campbell S; Hawley RJ; Sachs DH; Niklason LE; Qyang Y
Biomaterials; 2017 Dec; 147():116-132. PubMed ID: 28942128
[TBL] [Abstract][Full Text] [Related]
58. The Heart and Great Vessels.
Onwuka E; King N; Heuer E; Breuer C
Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28289246
[TBL] [Abstract][Full Text] [Related]
59. Micro- and Macrostructured PLGA/Gelatin Scaffolds Promote Early Cardiogenic Commitment of Human Mesenchymal Stem Cells In Vitro.
Cristallini C; Cibrario Rocchietti E; Gagliardi M; Mortati L; Saviozzi S; Bellotti E; Turinetto V; Sassi MP; Barbani N; Giachino C
Stem Cells Int; 2016; 2016():7176154. PubMed ID: 27822229
[TBL] [Abstract][Full Text] [Related]
60. The Tissue-Engineered Vascular Graft-Past, Present, and Future.
Pashneh-Tala S; MacNeil S; Claeyssens F
Tissue Eng Part B Rev; 2016 Feb; 22(1):68-100. PubMed ID: 26447530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
